Pathway
AMPK (AMP-Activated Protein Kinase)
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
What it is
AMPK is a heterotrimeric kinase that senses the AMP:ATP ratio. When ATP drops, AMP rises, and AMPK is activated. It then phosphorylates substrates that turn off energy-consuming processes (protein synthesis, lipogenesis) and turn on energy-producing ones (fatty-acid oxidation, mitochondrial biogenesis, autophagy).
Why it matters in aging
AMPK activity declines with age. Reactivation through caloric restriction, exercise, or pharmacological agonists (metformin, AICAR) opposes many hallmarks of aging: it suppresses mTOR, promotes autophagy, improves insulin sensitivity, and increases mitochondrial quality.
Activators
- Metformin (indirect, via complex I inhibition).
- Exercise (direct, via ATP demand).
- Caloric restriction and fasting.
- Berberine (modest data).
- Salicylates / aspirin (in vitro).
Cross-talk
- Inhibits mTORC1 via TSC2 phosphorylation and direct Raptor phosphorylation.
- Activates autophagy via ULK1.
- Activates PGC-1α for mitochondrial biogenesis (where applicable).
- Activates SIRT1 by raising NAD+.
Related entries
References
- Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121–135 (2018).